The market for Bioengineered Skin And Skin Substitutes Market is expected to reach USD XX Bn By 2023.
Bioengineered skin and soft tissue substitutes are generally derived from autologous or allogeneic human tissue, xenographic tissue, synthetic materials, or a composite. These products are being used and evaluated for treating a variety of conditions, such as breast reconstruction, thermal injury treatment, plastic surgeries, lower extremity ulcers, and others. Bioengineered and soft tissue substitutes can either be acellular or cellular. Acellular dermal matrix (ADM) contains a scaffold or matrix of materials like hyaluronic acid, collagen, and fibronectin. ADM products can be based on species sources, additives, hydration, tissue source, and preparation mode. Cellular products incorporate living cells, such as keratinocytes and fibroblasts, embedded in a matrix. The such cellular matter could be allogeneic, autologous, or even derived from another species. Skin substitutes are usually composed of epidermal cells, dermal cells, or a combination of both and provide growth factors.
Non-healing wounds are a chief application area of bioengineered skin and skin substitute products. This area potentially included diabetic ulcers, pressure ulcers, and vascular insufficiency ulcers. Such wounds do not adequately heal with conventional wound care and may lead to prolonged morbidity and an augmented risk of mortality. Bioengineered skin substitutes have the potential to improve healing rates in such treatments in a shorter amount of time and reduce the risk of complications. Second- and third-degree burns can also be effectively treated with bioactive skin and skin substitutes.
Product Type
Geography
LifeCell Corp., Bard Davol, Ethicon, LifeNet Health, Synthes, Tissue Regenix Wound Care, KCI, TEI Biosciences, Covidien plc, MiMedix, BioD, NuTech Medical, AlloSource, Medline Industries, Cook Biotech, Organogenesis, Shire Regenerative Medicine, Genzyme Biosurgery, Soluble Systems, Forticell Bioscience, Smith & Nephew, Integra LifeSciences, Advanced Tissue Sciences, and several others.
The market for Bioengineered Skin And Skin Substitutes Market is expected to reach USD XX Bn By 2023.
The Bioengineered Skin And Skin Substitutes Market is expected to see significant CAGR growth over the coming years, at XX%.
The report is forecasted from 2023.
The base year of this report is 2022.
LifeCell Corp., Bard Davol, Ethicon, LifeNet Health, Synthes, Tissue Regenix Wound Care, KCI, TEI Biosciences, Covidien plc, MiMedix, BioD, NuTech Medical, AlloSource, Medline Industries, Cook Biotech, Organogenesis, Shire Regenerative Medicine,are some of the major players in the global market.